Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry v3.7.0 was added to the record history and the previous revision v3.6.6 was removed. This updates the visible revision trail in the study history without changing substantive content.SummaryDifference0.1%

- Check49 days agoChange DetectedA new release note entry 'Revision: v3.6.6' was added to the history, and the previous 'Revision: v3.6.5' entry was removed, indicating an updated site version.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now lists a new revision v3.6.5 and removes v3.6.4 from the timeline, indicating a minor administrative update to the study record. This does not affect the study data or enrolled participants.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated on the history page from v3.6.3 to v3.6.4, indicating a recent software release for the site. This update appears in the version history and does not change the study data or visible content.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a new platform/UI version. This update does not modify study data or content on the page, just the version stamp.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.